Â鶹ӰԺ

Continuing what has been a busy year for the startup, Â鶹ӰԺ-based ColdQuanta has brought on $20 million to help commercialize its quantum computing technology. The investment brings ColdQuanta’s total funding to $74 million and comes from existing investors including Foundry Group, Global Frontier Quantum Opportunity Fund, LCP Quantum Partners and Maverick Ventures.

Solid Power, an industry-leading producer of all solid-state batteries for electric vehicles, today announced a $130 million Series B investment round. The investment positions Solid Power to produce full-scale automotive batteries, increase associated material output and expand in-house production capabilities for future vehicle integration.

As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now, Inscripta, a digital genome engineering company, has announced the first commercial shipment of its Onyx platform. The platform is the world's first fully automated benchtop instrument for genome-scale engineering. Inscripta also announced its Series E funding of $150 million.

Formerly NOHMs Technologies, the company combines proprietary electrolyte with a newly developed silicon anode design for a low-cost, high-performance and safer lithium-ion battery. In commercializing these latest silicon anode technologies, Sionic will collaborate with Mechanical Engineering Professor Sehee Lee’s lab and team of postdocs at the CU Â鶹ӰԺ. Over the past decade at the university, Dr. Lee’s team has created a legacy of Li-ion battery innovations that help drive the adoption of energy storage in products and their positive impact on climate change.

Researchers at CU Â鶹ӰԺ have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee and her team within the Department of Chemical and Biological Engineering.

CU Â鶹ӰԺ spinout ColdQuanta, the leader in Cold Atom Quantum Technology, has been awarded two development contracts from U.S. Government agencies worth $2.55M in total. Both projects are based on the company's Quantum Coreâ„¢ technology that uses atoms cooled to a temperature of nearly absolute zero, and lasers to manipulate and control the atoms with extreme precision.

CU Â鶹ӰԺ spinout SomaLogic Inc. is beginning a merger with a special purpose acquisition company CM Life Sciences II that would add up to $651 million in new funding to the company’s books, and make it Colorado’s latest unicorn. The deal values SomaLogic at $1.23 billion before going public, granting it unicorn status as a privately held company worth more than $1 billion.

Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyxâ„¢ platform and the closing of a $150 million Series E financing round led by Fidelity Management & Research Company LLC and funds and accounts advised by T. Rowe Price Associates, Inc.

TissueForm seeks to improve quality-of-life outcomes at lower costs for patients suffering from tissue disease, damage, or aging through stem cell and matrix-based therapies. The company—founded by Jeanne Barthold, PhD, and CU Â鶹ӰԺ Mechanical Engineering Associate Professor Corey Neu—is no stranger to the pitch competition circuit. TissueForm won $125,000 in Venture Partners' 2018 Lab Venture Challenge and took home multiple awards and more than $20,000 in CU Â鶹ӰԺ's New Venture Challenge 11.

CU spinouts Sachi Bioworks, Inc. and Vesicle Therapeutics, Inc. were two of four Colorado companies that pitched for the opportunity to receive Amgen mentoring and a $5,000 Amgen grant. The pitch event winner, SiVEC Biotechnologies, is an R&D company spun out of Colorado State University and based in Fort Collins. SiVEC is developing a platform technology for the manufacture and delivery of nucleic acids and holds a portfolio of intellectual property with relevance to human and animal health. The company was also a participating venture in the Venture Partners-hosted 2020 Destination Startup® event.